Stratos Wealth Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,727
Closed -$269K 1294
2022
Q1
$269K Buy
3,727
+53
+1% +$3.82K 0.01% 1032
2021
Q4
$337K Buy
3,674
+64
+2% +$7.65K 0.01% 960
2021
Q3
$458K Sell
3,610
-294
-8% -$42.8K 0.01% 781
2021
Q2
$649K Sell
3,904
-5,444
-58% -$882K 0.02% 691
2021
Q1
$1.7M Sell
9,348
-977
-9% -$227K 0.05% 349
2020
Q4
$2.06M Buy
10,325
+1,160
+13% +$236K 0.06% 268
2020
Q3
$2.01M Buy
9,165
+1,421
+18% +$301K 0.07% 262
2020
Q2
$1.48M Buy
7,744
+3,081
+66% +$540K 0.05% 304
2020
Q1
$723K Buy
4,663
+1,108
+31% +$129K 0.03% 407
2019
Q4
$298K Buy
3,555
+175
+5% +$13.3K 0.01% 761
2019
Q3
$229K Buy
+3,380
New +$222K 0.01% 832
2018
Q4
Sell
-735
Closed -$63K 2319
2018
Q3
$63K Sell
735
-2,705
-79% -$193K ﹤0.01% 1352
2018
Q2
$200K Buy
3,440
+80
+2% +$3.91K 0.01% 902
2018
Q1
$135K Buy
3,360
+165
+5% +$6.23K 0.01% 1050
2017
Q4
$111K Buy
+3,195
New +$106K 0.01% 1137

Other funds holding TDOC

Stratos Wealth Partners's TDOC Position: Q2 2022 in Review

Stratos Wealth Partners sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,727 shares — an estimated $269K sold.

Stratos Wealth Partners first reported a position in TDOC in Q4 2017 and held it in 15 quarters. The position peaked at $2.06M in Q4 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Stratos Wealth Partners reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Stratos Wealth Partners sold 3,727 Teladoc Health shares in Q2 2022, an estimated $269K.
  • Stratos Wealth Partners first reported a position in Teladoc Health in Q4 2017 and held it in 15 quarters.
  • Stratos Wealth Partners's Teladoc Health position peaked at $2.06M in Q4 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Stratos Wealth Partners's 13F filing for Q2 2022, filed 22 Jul 2022.